Pharmacytimes: Condition Center: COPD http://www.pharmacytimes.com/condition-resources/copd/condition-rss COPD en-us Thu, 24 May 2018 09:44:00 UTC Thu, 24 May 2018 09:44:00 UTC COPD Management Strategies and Minimizing Medication Waste in the Hospital Setting http://www.pharmacytimes.com/publications/issue/2018/May2018/R921_may2018 4:50 PM, Fri May 18, 2018 New Digital Platform is Increasing Inhaler Adherence http://www.pharmacytimes.com/contributor/timothy-aungst-pharmd/2018/05/new-digital-platform-is-increasing-inhaler-adherence Boehringer Ingelheim partnered with HealthPrize to deliver a platform that uses gamification, patient education, and tracking mechanics to help patients adherence with inhaler adherence, in a recent pilot study. 11:05 AM, Tue May 15, 2018 COPD: Causes, Stages, and Treatments http://www.pharmacytimes.com/publications/issue/2018/April2018/copd-causes-stages-and-treatments Chronic obstructive pulmonary disease is a broad term used to include chronic bronchitis, emphysema, or a combination of both. 1:00 PM, Mon April 23, 2018 Improving Lung Function (FEV1) in COPD Through Appropriate Counseling on Use of Inhaled Medications http://www.pharmacytimes.com/publications/issue/2018/March2018/r908_march2018 Chronic obstructive pulmonary disease (COPD) is a progressive, but treatable, disease characterized by airflow limitation and inflammation. 2:59 PM, Fri March 30, 2018 A Brief Look at the Clinical Uses of N-Acetylcysteine http://www.pharmacytimes.com/contributor/jola-mehmeti-pharmd-mba-candidate-2018/2018/03/a-brief-look-at-the-clinical-uses-of-nacetylcysteine- N-Acetylcysteine has several clinical uses. These include detoxification in acetaminophen overdose and improving outcomes in COPD exacerbations. 3:20 PM, Thu March 22, 2018 Pharmacist-Provided Spirometry: Reducing Barriers to Better Asthma Care http://www.pharmacytimes.com/resource-centers/asthma/pharmacistprovided-spirometry-reducing-barriers-to-better-asthma-care Asthma and chronic obstructive pulmonary disorder are chronic health conditions that need to be properly diagnosed to be managed effectively. 9:39 AM, Wed March 14, 2018 Understanding Asthma: Significant Research Contributions from 2017 http://www.pharmacytimes.com/resource-centers/asthma/understanding-asthma-significant-research-contributions-from-2017 An international team of respiratory disease specialists looked back at 2017 and assembled a review of the current approaches to asthma&nbsp;and chronic obstructive pulmonary disease. 2:00 PM, Mon March 5, 2018 Robot Shows Potential for Reducing COPD Readmission Rates http://www.pharmacytimes.com/contributor/timothy-aungst-pharmd/2018/02/robot-shows-potential-for-reducing-copd-readmission-rates A recent pilot looked into whether using a personal robot in a patients home could prevent readmission rates for those recently hospitalized with COPD. 1:00 PM, Wed February 28, 2018 Lonhala Magnair for COPD: What Pharmacists Should Know http://www.pharmacytimes.com/contributor/timothy-o-shea/2018/02/lonhala-magnair-for-copd-what-pharmacists-should-know The FDA approved this nebulized long-acting muscarinic antagonist in December 2017, and it is expected to be launched this spring. 4:53 AM, Fri February 23, 2018 Management of Community-Acquired Pneumonia in Adults http://www.pharmacytimes.com/resource-centers/copd/management-of-communityacquired-pneumonia-in-adults Here is an overview of the key Issues for hospital pharmacists. 5:20 PM, Mon January 15, 2018 FDA OKs First Nebulized LAMA COPD Treatment http://www.pharmacytimes.com/product-news/fda-oks-first-nebulized-lama-copd-treatment The FDA has approved glycopyrrolate (Lonhala Magnair, Sunovion) inhalation solution, also known as SUN-101/eFlow, the first nebulized long-acting muscarinic antagonist (LAMA) for the treatment of chronic obstructive pulmonary disease (COPD).<br /> &nbsp; 8:00 AM, Thu December 7, 2017 Trelegy Ellipta for COPD: What Pharmacists Should Know http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/12/trelegy-ellipta-for-copd-what-pharmacists-should-know The medication is indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease. 4:08 AM, Mon December 4, 2017 COPD: Delving Into Inhaler Adherence http://www.pharmacytimes.com/publications/issue/2017/November2017/copd-delving-into-inhaler-adherence Chronic obstructive pulmonary disease (COPD)&mdash;irreversible&mdash;requires long-term adherence to pharmacotherapies for&nbsp;best outcomes. 12:05 PM, Wed November 22, 2017 Express Scripts and Propeller Health Bringing Smart Inhalers to Market http://www.pharmacytimes.com/contributor/timothy-aungst-pharmd/2017/11/express-scripts-and-propeller-health-bringing-smart-inhalers-to-market Does this represent an opportunity for pharmacists to use such devices to help monitor adherence in patients? 11:58 PM, Sun November 19, 2017 Long-acting Medication Use in COPD: Opportunities for Minimizing Medication Waste in the Hospital Setting http://www.pharmacytimes.com/publications/issue/2017/November2017/R865_November2017 9:47 AM, Wed November 1, 2017 FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD http://www.pharmacytimes.com/product-news/fda-approves-first-oncedaily-single-inhaler-triple-therapy-for-copd Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). 1:12 PM, Tue September 19, 2017 Influenza vs. the Common Cold: Which One Is It? http://www.pharmacytimes.com/contributor/shelby-leheny-pharmd-candidate-2017/2017/08/influenza-vs-the-common-cold-which-one-is-it The thing is, you still may get sick after getting the flu because there are other things such as the common cold that might cross your path. 9:54 PM, Thu August 24, 2017 Global Burden of Disease: Asthma and COPD http://www.pharmacytimes.com/resource-centers/asthma/global-burden-of-disease-asthma-and-copd The prevalence of lung conditions worldwide has increased, despite the overall decrease in the prevalence and death rates for asthma between 1990 and 2015, according to the results of the 2015 Global Burden of Disease (GBD) Study. 11:20 AM, Thu August 17, 2017 Backing Up: Addressing Adherence Barriers in COPD http://www.pharmacytimes.com/resource-centers/copd/backing-up-addressing-adherence-barriers-in-copd Patients with chronic obstructive pulmonary disease (COPD) often have difficulty adhering to medications, leading to exacerbations, and often hospitalization. 10:26 AM, Mon August 7, 2017 How Can Pharmacists Improve Flu Vaccination Rates in Patients with COPD? http://www.pharmacytimes.com/resource-centers/flu/how-can-pharmacists-improve-flu-vaccination-rates-in-patients-with-copd Pharmacists can play a crucial role in promoting the flu vaccine to these patients by recognizing the characteristics of those who do not seek vaccinations. 10:52 AM, Wed August 2, 2017